The Global Tretinoin Market is anticipated to gain popularity over the coming years as tretinoin products are used to treat acute promyelocytic leukemia and acne. This information was announced by Fortune Business Insights in a report, titled “Tretinoin Market Size, Share and Global Trend by Application (Acne, Acute Promyelocytic Leukemia (APL)), By Strength (0.025%, 0.01%, 0.05%, 0.1%), By Distribution Channel (Hospitals & Clinics Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of administration (Topical Applications, Oral), Geography Forecast till 2026.” Tretinoin also referred to as Retin-A helps to treat skin discoloration and aging.
The report mentions that the demand for tretinoin products in hospitals, retail, and online pharmacies is likely to increase in the coming years. Furthermore, as per the report, acne treatment accounts for a major share in the global market at present and continues to remain strong in the forecast years. This is ascribable to the rising use of tretinoin for acne vulgaris as compared to acute promyelocytic leukemia.
Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/tretinoin-market-100194
Demand for Tretinoin Products is the Highest in North America and Europe
Among regions, North America and Europe are anticipated to hold a major share in the global tretinoin market throughout the forecast years. The rising prevalence of acne vulgaris in the U.S. is the main factor likely to drive the market in this region. Also, rising FDA approvals for the treatment of acne is expected to create growth opportunities for the market by 2026. Well-established healthcare infrastructure is expected to encourage growth in the market in Europe by 2026. The market in Asia Pacific is likely to register considerable growth during the forecast period. Japan is projected to offer the largest market opportunity owing to the presence of a drug manufacturer called Chugai. The manufacturing unit is controlled by F. Hoffmann-La Roche AG in Japan.
Extensive Use of Tretinoin Products Stimulates Growth in the Market
Tretinoin, a derivative of vitamin A helps to treat mild to moderate acne on the skin, which is damaged by excessive sun exposure. Other benefits offered by tretinoin include treatment for hyperpigmentation and wrinkles. As per research studies, use of tretinoin cream over a long term helps to reduce the visibility of skin aging symptoms. The report predicts such benefits to augment demand for tretinoin cream and tretinoin microsphere gel in the coming years.
“Launch of new products and existing number of products for all-trans retinoic acid leukemia are likely to drive the market,” stated a lead analyst at Fortune Business Insights. “The demand for such products in different strengths and forms is expected to increase, which is indicative of boosting the tretinoin market,” he added. As per the American Academy of Dermatology or AAD, over 50 million Americans get affected by acne conditions every year. Furthermore, the study suggested that administration of tretinoin for skin is the most effective treatment. The tremendous benefits offered by tretinoin products are expected to propel growth in the market between 2018 and 2026.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/tretinoin-market-100194
Adverse Effects of Tretinoin Products May Hamper Growth
Certain factors that may inhibit the growth of the market include side effects of tretinoin products. These side effects such as itching, excessive dryness, redness, and scaling may restrict the market’s growth. Also, administration of tretinoin for the treatment of leukemia can have some side effects such as retinoic acid syndrome, liver damage, hypertension, and others. These side-effects may pose a serious threat to the market during the forecast duration.
FDA Approvals for the Treatment of Acne Encourages Companies to Expand their Product Offering
Some of the leading players in the global tretinoin market are Ortho Dermatologics, Sun Pharmaceutical Industries Ltd., Mylan Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Glaxosmithkline Inc., and Bausch Health Companies Inc. Some of the companies received FDA approvals for treating acute conditions of acne, which in turn, will encourage product expansion. Some of the recent FDA approvals are:
- Ortho Dermatologics received FDA approval in August 2018 on its first-ever tretinoin product called Altrena. This product is developed in the form of a lotion to effectively treat acne.
- An efficacy clinical trial on trans-retinoic acid (tretinoin) is underway in Phase 2 as of June 2018 at Yale University in the U.S. The trial was initiated for patients suffering from Primary Sclerosing Cholangitis.
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245